BACKGROUND: Complete pathological resection of locally advanced or recurrent @entity5 is regarded as one of the most important determinants of oncological outcome. Disease in the lateral pelvic sidewall has been considered a contraindication for pelvic exenteration surgery owing to the significant likelihood of incomplete resection. METHODS: We describe a novel technique (ELSiE) to resect disease involving the lateral pelvic sidewall. @entity1 demographics, post-operative histology, length of hospital stay and complications were collected from prospectively maintained electronic @entity1 database. RESULTS: During 2011-2013, six @entity1 underwent pelvic exenteration surgery with the ELSiE approach. All @entity1 had R0 resection. Three @entity1 required sciatic nerve excision. Four @entity1 developed post-operative complications although no major complications occurred. CONCLUSIONS: @entity1 with locally advanced and recurrent @entity5 involving the lateral pelvic sidewall may be rendered suitable for potentially curative radical resection with a modification in the approach to the lateral pelvic sidewall. Our pilot series seems to indicate that our novel technique (ELSiE) is feasible, safe and yields high rates of complete pathological resection.

Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent XXXX involving the pelvic sidewall.

@entity5 :: ('MESH:D009369', 'Disease') :: ['rectal and anal cancer', 'cancer'] @entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'Patient']
@entity5 :: (MESH:D009369,Disease) :: ['anorectal cancer']
